BioSpace News Archive

Vystar Corporation (OTCQB: VYST) and the Indian Rubber Manufactu rers Research Association (IRMRA) have signed a Memorandum of Understanding (MoU) for a wide range of collaborative activities, including but not limited to research, innovation, testing and technology transfer in midstream and downstream sectors of the rubber industry. IRMRA is an internationally renowned Research and Development Centre

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today new data from its clinical trial demonstrating an almost doubling of immune cell activity in healthy volunteers

Prescient Medicine Holdings, Inc., a privately held company focused on developing insights-based health tools, today announced its rebrand to SOLVD Health. The new name and brand reflect the comp

Calviri, a biotechnology company developing unique products against cancer, is pleased to announce that it was awarded one of three Platinum awards in the Pepperdine Graziadio Business School’s third annual Most Fundable Companies® List.

Sapience Therapeutics, Inc., a clinical stage biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, announced today that it has appointed J. Andrew Sanford to its Board of Directors.

Versant Health, a leading managing vision care company, has designated December as Gift of Sight Month, in honor of the wonders afforded by regular eye care and healthy vision during the holiday season

Cellaria Inc (Wakefield, MA, USA) and the Spring Lab, Northeastern University, announce the successful receipt of a National Institutes of Health (NIH) R01 grant to extend and advance the application of innovative new photomedicine-based therapies for hard-to-treat cancers. The grant highlights the close working relationshi

The first manufacturing service of its kind delivers tested sterile, non-GMP media designed for feasibility testing before scale-up, to support development of cell and gene therapies

The Romanian Startup .lumen (dotLumen), has just released details on the first glasses designed specifically to help the mobility of the blind.

Samumed, LLC, a clinical-stage biotechnology company pioneering therapeutics based on RNA alternative splicing for major diseases, announced today that Dr. Darrin M. Beaupre will join the company as its Chief Medical Officer, Oncology.